Clinical Trial Detail

NCT ID NCT03232892
Title Trametinib in Patients With Advanced Neurofibromatosis Type 1 (NF1)-Mutant Non-small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications

lung non-small cell carcinoma

Therapies

Trametinib

Age Groups: adult senior

No variant requirements are available.